CI EBITDA | The Cigna Group

The Cigna Group (CI) EBITDA

2026-06-30: Basis Reported; EBITDA $3.33B; Operating income (m); Depreciation and amortization (m).
2026-03-31: Basis Reported; EBITDA $3.01B; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA $3.07B; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA $3.28B; Operating income (m); Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history: 2016-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	$3.33B	(m)	(m)	(m)	4.65%	(m)	-$421.00M*	$56.70B	(m)	$3.47B	$382.00M
2026-03-31	Reported	$3.01B	(m)	(m)	(m)	4.39%	(m)	$1.13B	$54.10B	(m)	$3.72B	$409.00M
2025-12-31	Reported	$3.07B	(m)	(m)	(m)	4.23%	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	$3.28B	(m)	(m)	(m)	4.70%	(m)	$3.42B*	$55.53B	(m)	$3.36B	$322.00M
2025-06-30	Reported	$2.99B	(m)	(m)	(m)	4.45%	(m)	-$1.89B*	$53.27B	(m)	$3.43B	$389.00M
2025-03-31	Reported	$2.65B	(m)	(m)	(m)	4.04%	(m)	$1.92B	$48.40B	(m)	$4.21B	$239.00M
2024-12-31	Reported	$2.82B	(m)	(m)	(m)	4.29%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	$3.23B	(m)	(m)	(m)	5.06%	(m)	$46.00M*	$47.56B	(m)	$3.59B	$367.00M
2024-06-30	Reported	$3.15B	(m)	(m)	(m)	5.20%	(m)	$265.00M*	$44.49B	(m)	$3.68B	$360.00M
2024-03-31	Reported	$3B	(m)	(m)	(m)	5.23%	(m)	$4.84B	$41.43B	(m)	$3.71B	$291.00M
2023-12-31	Reported	$2.83B	(m)	(m)	(m)	5.53%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	$3.01B*	$2.24B	$766.00M*	(m)	(m)	(m)	$2.83B*	$33.64B	(m)	$3.79B	$391.00M
2023-06-30	Reported	$2.98B*	$2.22B	$755.00M*	(m)	(m)	(m)	$2.49B*	$33.44B	(m)	$3.43B	$374.00M
2023-03-31	Reported	$2.76B	(m)	(m)	(m)	5.94%	(m)	$5.03B	$31.46B	(m)	$3.54B	$295.00M
2022-12-31	Reported	$2.48B	(m)	(m)	(m)	5.43%	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	$2.87B*	$2.14B	$726.00M*	(m)	(m)	(m)	$3.28B*	$31.78B	(m)	$3.15B	$713.00M
2022-06-30	Reported	$3.13B*	$2.37B	$759.00M*	(m)	(m)	(m)	$1.24B*	$31.15B	(m)	$3.26B	$411.00M
2022-03-31	Reported	$2.91B	(m)	(m)	(m)	6.60%	(m)	$2.03B	$29.81B	(m)	$3.27B	$355.00M
2021-12-31	Reported	$2.29B	(m)	(m)	(m)	5.00%	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Reported	$3.03B*	$2.29B	$734.00M*	(m)	(m)	(m)	$2.12B*	$30.07B	(m)	$3.09B	$424.00M
2021-06-30	Reported	$2.88B*	$2.15B	$731.00M*	(m)	(m)	(m)	-$296.00M*	$29.00B	(m)	$3.00B	$422.00M
2021-03-31	Reported	$2.67B	(m)	(m)	(m)	6.52%	(m)	$1.09B	$27.23B	(m)	$3.28B	$342.00M
2020-12-31	Reported	$2.06B	(m)	(m)	(m)	4.93%	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	$2.81B*	$2.11B	$702.00M*	(m)	(m)	(m)	$895.00M*	$26.62B	(m)	$3.30B	$406.00M
2020-06-30	Reported	$3.33B*	$2.64B	$694.00M*	(m)	(m)	(m)	$3.27B*	$25.61B	(m)	$3.41B	$529.00M
2020-03-31	Reported	$2.75B	(m)	(m)	(m)	7.16%	(m)	$1.89B	$24.19B	(m)	$3.40B	$208.00M
2019-12-31	Reported	$2.49B	(m)	(m)	(m)	6.51%	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	$3.04B*	$2.12B	$913.00M*	(m)	(m)	$243.00M*	$2.46B*	$24.55B	(m)	$3.41B	$409.00M
2019-06-30	Reported	$3.08B*	$2.16B	$914.00M*	(m)	(m)	$303.00M*	$1.04B*	$24.96B	(m)	$3.38B	$348.00M
2019-03-31	Reported	$3.13B	(m)	(m)	(m)	8.24%	$194.00M	$3.19B	$24.05B	(m)	$3.30B	$416.00M
2018-12-31	Reported	$816M	(m)	(m)	(m)	5.71%	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Reported	$1.29B*	$1.13B	$162.00M*	(m)	(m)	$126.00M*	$624.00M*	$602.00M	(m)	$2.87B	$259.00M
2018-06-30	Reported	$1.30B*	$1.16B	$136.00M*	(m)	(m)	$117.00M*	$995.00M*	$613.00M	(m)	$2.84B	$294.00M
2018-03-31	Reported	$1.45B	(m)	(m)	(m)	12.69%	$103.00M	$2.02B	$561.00M	(m)	$2.75B	$301.00M

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	$11.98B	(m)	(m)	(m)	4.36%	(m)	$9.60B	$214.99B	(m)	$14.62B	$1.49B
2024-12-31	Reported	$12.19B	(m)	(m)	(m)	4.93%	(m)	$10.36B	$182.51B	(m)	$14.84B	$1.49B
2023-12-31	Reported	$11.57B	(m)	(m)	(m)	5.93%	(m)	$11.81B	$133.80B	(m)	$14.82B	$141.00M
2022-12-31	Reported	$11.39B	(m)	(m)	(m)	6.31%	(m)	$8.66B	$124.83B	(m)	$13.17B	$1.61B
2021-12-31	Reported	$10.86B	(m)	(m)	(m)	6.24%	(m)	$7.19B	$117.55B	(m)	$13.01B	$1.37B
2020-12-31	Reported	$10.96B	(m)	(m)	(m)	6.83%	(m)	$10.35B	$103.48B	(m)	$14.07B	$2.38B
2019-12-31	Reported	$11.73B	(m)	(m)	(m)	7.64%	$1.05B	$9.48B	$97.67B	(m)	$14.05B	$1.45B
2018-12-31	Reported	$4.86B	(m)	(m)	(m)	9.98%	$528.00M	$3.77B	$4.79B	(m)	$11.93B	$935.00M
2017-12-31	Reported	$4.51B	(m)	(m)	(m)	10.78%	$471.00M	$4.09B	$2.46B	(m)	$10.03B	$1.37B
2016-12-31	Reported	$3.7B	(m)	(m)	(m)	9.28%	$461.00M	$4.03B	$2.47B	(m)	$9.79B	$1.14B

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Elevance Health, Inc. (ELV)	United States	$86.364B	16.90
HUMANA INC (HUM)	United States	$45.651B	18.44
CENTENE CORP (CNC)	United States	$30.588B	-6.22
MOLINA HEALTHCARE, INC. (MOH)	United States	$10.091B	-1,697.50
Alignment Healthcare, Inc. (ALHC)	United States	$1.593B	121.28
TRUPANION, INC. (TRUP)	United States	$0.984B
UNITEDHEALTH GROUP INC (UNH)	United States	$336.652B	26.62